SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-18-062929
Filing Date
2018-12-17
Accepted
2018-12-17 16:15:40
Documents
1
Period of Report
2018-10-17

Document Format Files

Seq Description Document Type Size
1 FORM 3/A SUBMISSION doc3a.html 3/A  
1 FORM 3/A SUBMISSION doc3a.xml 3/A 2429
  Complete submission text file 0001209191-18-062929.txt   4050
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Issuer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PHASEBIO PHARMACEUTICALS, INC. 1 GREAT VALLEY PKWY., SUITE 30 MALVERN PA 19355
Business Address
Ballance David James (Reporting) CIK: 0001755432 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-38697 | Film No.: 181238302